Hunan Huana Pharmaceuticals

Hunan Huana Pharmaceuticals is a China-based pharmaceutical company specializing in the research, development, production, and sale of chemical drug preparations and active pharmaceutical ingredients (APIs). The company operates a vertically integrated business model, maintaining high-standard GMP manufacturing facilities for both raw materials and finished dosages across several therapeutic areas, including digestive, respiratory, and anti-infective systems. Listed on the Shanghai Stock Exchange STAR Market, Huana is increasingly focusing on the transition from high-end generics to innovative small molecule drug discovery. Their product portfolio includes widely used treatments such as Pantoprazole Sodium and Ambroxol Hydrochloride, supported by a robust R&D infrastructure in Changsha.